In just the last 10 years, biopharmaceutical supply chains have changed dramatically. The single-source manufacturing model is becoming much rarer, making way for multi-enterprise manufacturing collaborations and partnerships to better meet the changing needs of the life sciences marketplace.
In collaboration with other life sciences leaders, Emerson's Michalle Adkins contributed to a BioPhorum paper outlining a vision for digital maturity in the integration between biomanufacturers and partner organizations. The paper explores the benefits for improved digital integration to improve the patient experience while simultaneously improving business outcomes.
Digital integration breeds standardization
At the heart of this transition to improved digital integration is standardizing approaches to integration. Currently, many organizations operate under highly complex digital integration architectures. As the paper details, The experts suggest that an industry standard approach to data and information sharing is the key to improving operations and maintaining scalability as the trend toward collaborations and partnerships continues to shape the life sciences landscape.
